Carillon Tower Advisers’s NuVasive, Inc. NUVA Stock Holding History

Carillon Tower Advisers’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$21.6M	Buy	382,889 +189,402	+98%	+$9.32M	0.13%	230
2020 Q3	$9.4M	Sell	193,487 -323,995	-63%	-$17.5M	0.13%	262
2020 Q2	$28.8M	Buy	517,482 +132,025	+34%	+$7.64M	0.22%	143
2020 Q1	$17.3M	Sell	385,457 -74,083	-16%	-$4.97M	0.17%	194
2019 Q4	$35.5M	Hold	459,540	–	–	0.24%	148
2019 Q3	$29.1M	Buy	459,540 +87,926	+24%	+$5.5M	0.2%	167
2019 Q2	$21.8M	Hold	371,614	–	–	0.15%	242
2019 Q1	$21.1M	Sell	371,614 -367,425	-50%	-$19.5M	0.15%	235
2018 Q4	$36.6M	Hold	739,039	–	–	0.31%	114
2018 Q3	$52.5M	Hold	739,039	–	–	0.38%	84
2018 Q2	$38.5M	Hold	739,039	–	–	0.3%	119
2018 Q1	$39.2M	Hold	739,039	–	–	0.31%	104
2017 Q4	$43.2K	Buy	+739,039	New	+$41.9M	0.46%	66

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Carillon Tower Advisers's NUVA Position: Q4 2020 in Review

Carillon Tower Advisers increased its NuVasive, Inc. (NUVA) stake by 98% in Q4 2020, buying an estimated $9.32M and bringing the position to 382,889 shares worth $21.6M. The position accounts for 0.13% of the portfolio, ranked #230.

Carillon Tower Advisers first reported a position in NUVA in Q4 2017 and has held it in 13 quarters since. The position peaked at $52.5M in Q3 2018. 280 funds tracked by Wall St. Rank hold NUVA as of Q4 2020.

Carillon Tower Advisers held 382,889 shares of NuVasive, Inc. worth $21.6M as of Q4 2020.
Carillon Tower Advisers bought 189,402 NuVasive, Inc. shares in Q4 2020, an estimated $9.32M.
NuVasive, Inc. made up 0.13% of Carillon Tower Advisers's portfolio in Q4 2020, its #230 holding.
Carillon Tower Advisers first reported a position in NuVasive, Inc. in Q4 2017 and has held it in 13 quarters since.
Carillon Tower Advisers's NuVasive, Inc. position peaked at $52.5M in Q3 2018.
280 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.